|
Volumn 62, Issue 9, 2001, Pages 1163-1173
|
Inhibition of human mast cell activation with the novel selective adenosine A2B receptor antagonist 3-isobutyl-8-pyrrolidinoxanthine (IPDX)
|
Author keywords
Adenosine; Asthma; Interleukin 8; Mast cells; P1; Receptors purinergic; Xanthines
|
Indexed keywords
3 ISOBUTYL 8 PYRROLIDINOXANTHINE;
4 [2 [7 AMINO 2 (2 FURYL) 1,2,4 TRIAZOLO[2,3 A][1,3,5]TRIAZIN 5 YLAMINO]ETHYL]PHENOL;
ADENOSINE;
ADENOSINE 5' (N ETHYLCARBOXAMIDE);
ADENOSINE A1 RECEPTOR;
ADENOSINE A2 RECEPTOR ANTAGONIST;
ADENOSINE A2A RECEPTOR;
ADENOSINE A2B RECEPTOR;
ADENOSINE A3 RECEPTOR;
ANTIASTHMATIC AGENT;
CYCLIC AMP;
ENPROFYLLINE;
INTERLEUKIN 8;
TRITIUM;
UNCLASSIFIED DRUG;
XANTHINE DERIVATIVE;
ANIMAL CELL;
ARTICLE;
ASTHMA;
BRONCHOSPASM;
CELL ACTIVATION;
CONTROLLED STUDY;
CYTOKINE RELEASE;
DRUG POTENCY;
DRUG SELECTIVITY;
ERYTHROLEUKEMIA CELL;
HUMAN;
HUMAN CELL;
MAST CELL;
NONHUMAN;
PRIORITY JOURNAL;
RECEPTOR AFFINITY;
STRUCTURE ACTIVITY RELATION;
NON-PROGRAMMATIC;
ADENOSINE;
ADENOSINE-5'-(N-ETHYLCARBOXAMIDE);
ANTI-ASTHMATIC AGENTS;
CELLS, CULTURED;
HUMANS;
MAST CELLS;
PYRROLIDINONES;
RECEPTOR, ADENOSINE A2B;
RECEPTORS, PURINERGIC P1;
STRUCTURE-ACTIVITY RELATIONSHIP;
VASODILATOR AGENTS;
XANTHINE;
XANTHINES;
|
EID: 0035504657
PISSN: 00062952
EISSN: None
Source Type: Journal
DOI: 10.1016/S0006-2952(01)00765-1 Document Type: Article |
Times cited : (71)
|
References (33)
|